Artificial intelligence has great potential to transform health care for women if we can mitigate AI's tendency for propagating biases against women in health data.
Over 20,000 women will be diagnosed with ovarian cancer this year in the United States, and less than half of them will still be alive in five years.
Women’s Health Research Day celebrates the day that NIH’s policy requiring inclusion of sex as a biological variable in research took effect.
SWHR CEO Amy M. Miller announces that she is leaving in 2020 and SWHR begins search for new leader.
A report from the National Pharmaceutical Council (NPC) concludes that there is no “best” framework for determining the value of a health care product.
Women veterans are two times more likely than non-veteran women to die by suicide, and there is a dire need to improve their access to mental health services.
SWHR remembers former SWHR Board member Bruce McEwen, PhD, who passed away on January 2, 2020.
When a new health care innovation comes to market, how do patients, health care providers, and health care payers determine its value?
SWHR and FasterCures, a center of the Milken Institute, released a report outlining the positive changes for women’s health research from the 21st Century Cures Act.